Xinchen Duan
Xinchen Duan graduated from Zhejiang University and joined the Master of medical science in clinical investigation program at Harvard medical school in July 2019. At CTEU, he has been working since September 2019 as a research intern on several clinical trials including studying the effects of aspirin on MIC1 levels. He is jointly mentored by Dr. Andrew Chan and Dr. David Drew. His research interest is focused on gastrointestinal cancer, IBD, medical translation and pharm-economic study.
Zhe (Gigi) Fang, MBBS, BS
Gigi Fang is a second-year master student in Department of Epidemiology, Harvard T.H. Chan School of Public Health. She has her bachelor’s degree in Medicine and a bachelor’s degree in Economics from Peking University. Gigi joined CTEU in 2020 and is mentored by Dr. Mingyang Song. Her research interests focus on identifying dietary, genetic, and biomedical determinants of cancers and cardiometabolic diseases, as well as integrating state-of-the-art techniques (e.g. GWAS, metabolomic, microbiome) into large cohort studies to better understand the etiology and causal pathways.
Jennifer Le
Jennifer joined the Warner Lab as a COVID Corps Intern in July 2020, helping with a survey to examine the effects of the COVID-19 pandemic on breast cancer care. As she finishes her senior year at UMass Amherst with a major in Microbiology, her new project is looking at how the pandemic will be affecting the health of school staff and faculty in the Greater Boston Area.
Daniel Sikavi
Daniel Sikavi is an M.D. student at Harvard Medical School. His research interests include dietary and other environmental exposures that underlie gastrointestinal malignancies. He earned an A.B. in Ecology & Evolutionary Biology and a certificate in Global Health & Health Policy from Princeton University.
Jeffrey Wang, BS
Jeffrey Wang joined in September 2020 as an NIH NRSA Predoctoral Fellow. He graduated from the Johns Hopkins University with a B.S. in Neuroscience and a minor in Psychology. Jeffrey’s research interests focuses on non-alcoholic fatty liver disease (NAFLD) and the development of non-invasive biomarkers for the diagnosis and monitoring of NAFLD. He works on several clinical trials and translational studies, ranging in topics from coronavirus disease 2019 (COVID-19) to chronic liver diseases including hepatitis C (HepC) and NAFLD. He will be mentored by: Dr. Kathleen Corey & Dr. Tracey Simon.